Clinical

Discover how the Proteomics and Metabolomics Shared Resource helps advance research at St. Jude.

Using genetic information to inform clinical care, researchers and clinicians at St. Jude identified a new treatment for Maria Tangonan that led to a first-of-its-kind cure for pediatric refractory high-risk neuroblastoma.

Through art and audio, three patients and research participants narrate their experiences with HIV treatment and prevention at St. Jude.

The EAGER Clinic offers holistic care for adolescents in Memphis and surrounding communities who experience heavy menstrual bleeding and iron-deficiency anemia.

Researchers at St. Jude are investigating how to approach difficult conversations about prognosis with patients and their families.

St. Jude scientists contributed to a phase 3 clinical trial showing that blinatumomab added to chemotherapy is effective against leukemia in adults.

Childhood cancer survivors are at an increased risk of major adverse cardiovascular events, making safeguarding heart health a priority.

Factors like family anxiety and neighborhood adversity contribute to symptom burden in childhood cancer survivors and the need for comprehensive care.

Phase II clinical trial results show promise in reducing graft-versus-host disease

Closing the time gap between pediatric and adult care could have significant benefits for patients.